Koyfin Home > Directory > Health Care > LA Jolla Pharma > Capital Expenditures

LA Jolla Pharma Capital Expenditures Chart (LJPC)

LA Jolla Pharma annual/quarterly Capital Expenditures from 2013 to 2019.
  • LA Jolla Pharma Capital Expenditures for the quarter ending December 12, 2019 was $0m a -868.42% increase of 0m year over year
  • LA Jolla Pharma Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a -198.44% increase of 1m year over year
  • LA Jolla Pharma Annual Capital Expenditures for 2019 was $-1m a -235.24% increase of 2m from 2018
  • LA Jolla Pharma Annual Capital Expenditures for 2018 was $-2m a -292.91% increase of 7m from 2017
  • LA Jolla Pharma Annual Capital Expenditures for 2017 was $-9m a 75.88% decrease of -7m from 2016
Other Cash Flow Metrics:
  • LA Jolla Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-32m a -43.12% increase of 14m year over year
  • LA Jolla Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-50m a 42.74% decrease of -22m year over year
  • LA Jolla Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a 97.55% increase of 3m year over year
View Chart On Koyfin

Quarterly LJPC Capital Expenditures Data

12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$-1m
03/2018$-1m
12/2017$-5m
09/2017$-2m

Annual LJPC Capital Expenditures Data

2019$-1m
2018$-2m
2017$-9m
2016$-2m
2015$-2m
2014$0m
2013$0m